1. Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin

2. Program Goals

12. Canagliflozin Use in Older Patients With Type 2 Diabetes: Safety and Efficacy

19. Inhibiting SGLT-2 Receptors: Clinical Implications

27. Attainment of Diabetes-related Goals With Canagliflozin

36. Abbreviations

37. Abbreviations (cont)

38. References

39. References (cont)

40. References (cont)

41. References (cont)

42. References (cont)

43. References (cont)

44. References (cont)

45. References (cont)

46. References (cont)